CompletedNot Applicable

Three Different Modalities for Treatment of Inflammatory Punctal Stenosis

Egypt60 participantsStarted 2023-07-20

Plain-language summary

This study aimed to compare the efficacy of three various modalities of treatment of inflammatory punctal stenosis (Punctal dilatation alone, combined punctal dilatation with topical medications, or peri-punctal injection of Triamcinolone acetonide)

Who can participate

Age range33 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age from 33 to 75. * Both sexes. * Patients with inflammatory punctal stenosis or occlusion complaining of symptomatic epiphora. Exclusion Criteria: * Subjects with previous lacrimal surgeries. * Subjects with lid margin malposition such as ectropion, entropion, or lid retraction. * Subjects with medial lid masses obscuring the punctum. * Subjects with a history of ocular trauma involving the medial aspect of the lid margin.

What they're measuring

Degree of patient satisfaction

Timeframe: 3 months postoperatively

Trial details

NCT IDNCT06798025

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-30

View on ClinicalTrials.gov More Modalities trials